BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27387825)

  • 1. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
    Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
    Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.
    Lee M; Yang J; Jo E; Lee JY; Kim HY; Bartenschlager R; Shin EC; Bae YS; Windisch MP
    Sci Rep; 2017 Mar; 7():44676. PubMed ID: 28333153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
    Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
    Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methanolic Extract of
    Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.
    Kim HY; Kong S; Oh S; Yang J; Jo E; Ko Y; Kim SH; Hwang JY; Song R; Windisch MP
    Antiviral Res; 2016 May; 129():39-46. PubMed ID: 26850830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
    Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
    Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
    Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
    J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes.
    Qian XJ; Zhang XL; Zhao P; Jin YS; Chen HS; Xu QQ; Ren H; Zhu SY; Tang HL; Zhu YZ; Qi ZT
    Sci Rep; 2016 Jun; 6():27268. PubMed ID: 27252043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.
    Yin P; Zhang L; Ye F; Deng Y; Lu S; Li YP; Zhang L; Tan W
    Sci Rep; 2017 Jun; 7(1):3976. PubMed ID: 28638089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel small molecule inhibitor of hepatitis C virus entry.
    Baldick CJ; Wichroski MJ; Pendri A; Walsh AW; Fang J; Mazzucco CE; Pokornowski KA; Rose RE; Eggers BJ; Hsu M; Zhai W; Zhai G; Gerritz SW; Poss MA; Meanwell NA; Cockett MI; Tenney DJ
    PLoS Pathog; 2010 Sep; 6(9):e1001086. PubMed ID: 20838466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.
    Coburn GA; Fisch DN; Moorji SM; de Muys JM; Murga JD; Paul D; Provoncha KP; Rotshteyn Y; Han AQ; Qian D; Maddon PJ; Olson WC
    PLoS One; 2012; 7(4):e35351. PubMed ID: 22545104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway.
    Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT
    EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
    Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT
    Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
    Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry.
    Chung CY; Liu CH; Wang GH; Jassey A; Li CL; Chen L; Yen MH; Lin CC; Lin LT
    Sci Rep; 2016 Jul; 6():29969. PubMed ID: 27426693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry.
    Behrendt P; Perin P; Menzel N; Banda D; Pfaender S; Alves MP; Thiel V; Meuleman P; Colpitts CC; Schang LM; Vondran FWR; Anggakusuma ; Manns MP; Steinmann E; Pietschmann T
    Antiviral Res; 2017 Nov; 147():19-28. PubMed ID: 28923507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antimalarial ferroquine is an inhibitor of hepatitis C virus.
    Vausselin T; Calland N; Belouzard S; Descamps V; Douam F; Helle F; François C; Lavillette D; Duverlie G; Wahid A; Fénéant L; Cocquerel L; Guérardel Y; Wychowski C; Biot C; Dubuisson J
    Hepatology; 2013 Jul; 58(1):86-97. PubMed ID: 23348596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C viral entry inhibitors prolong viral suppression by replication inhibitors in persistently-infected Huh7 cultures.
    Bush CO; Greenstein AE; Delaney WE; Beran RK
    PLoS One; 2013; 8(6):e65273. PubMed ID: 23755208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.